Ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy: Semper Discere (Always Learning).
作者信息
Estes N A Mark, Wong Timothy C
机构信息
From the University of Pittsburgh Medical Center Heart and Vascular Institute University of Pittsburgh School of Medicine Pittsburgh PA.
出版信息
J Am Heart Assoc. 2021 Feb 2;10(3):e019876. doi: 10.1161/JAHA.120.019876. Epub 2021 Jan 17.
Abstract
摘要
相似文献
1
Ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy: Semper Discere (Always Learning).肥厚型心肌病患者心房颤动的消融治疗：永远学习
J Am Heart Assoc. 2021 Feb 2;10(3):e019876. doi: 10.1161/JAHA.120.019876. Epub 2021 Jan 17.
2
Ablation of atrial fibrillation in the setting of hypertrophic cardiomyopathy.肥厚型心肌病背景下的心房颤动消融术。
J Cardiovasc Electrophysiol. 2008 Oct;19(10):1015-6. doi: 10.1111/j.1540-8167.2008.01230.x. Epub 2008 Jun 28.
3
Atrial fibrillation ablation in patients with hypertrophic cardiomyopathy: do not throw in the towel too fast!肥厚型心肌病患者的心房颤动消融术：不要过早放弃！
Europace. 2021 Sep 8;23(9):1334-1335. doi: 10.1093/europace/euab040.
4
Atrial fibrillation and hypertrophic cardiomyopathy: More progress needed.心房颤动与肥厚型心肌病：仍需更多进展。
J Cardiovasc Electrophysiol. 2021 Mar;32(3):667-668. doi: 10.1111/jce.14874. Epub 2021 Jan 24.
5
Atrial fibrillation ablation in patients with hypertrophic cardiomyopathy: long-term outcomes and clinical predictors.
J Am Coll Cardiol. 2015 Apr 14;65(14):1485-7. doi: 10.1016/j.jacc.2014.12.063.
6
Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy.肥厚型梗阻性心肌病患者行心肌切除术同期行房颤消融术。
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1536-1542.e2. doi: 10.1016/j.jtcvs.2017.08.063. Epub 2017 Sep 1.
7
Outcomes of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.
Am J Cardiol. 2023 Nov 15;207:1-3. doi: 10.1016/j.amjcard.2023.08.156. Epub 2023 Sep 15.
8
Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者房颤导管消融术后结局的底物和程序预测因素
J Cardiovasc Electrophysiol. 2008 Oct;19(10):1009-14. doi: 10.1111/j.1540-8167.2008.01192.x. Epub 2008 May 9.
9
Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy patients: a systematic review.肥厚型心肌病患者心房颤动的导管消融：一项系统评价
J Interv Card Electrophysiol. 2015 Nov;44(2):161-70. doi: 10.1007/s10840-015-0047-8. Epub 2015 Aug 25.
10
Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study.肥厚型心肌病患者心房颤动的导管消融：一项欧洲观察性多中心研究。
Europace. 2021 Sep 8;23(9):1409-1417. doi: 10.1093/europace/euab022.
本文引用的文献
1
Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Treatment Strategy, Characteristics of Consecutive Atrial Tachycardia and Long-Term Outcome.肥厚型心肌病患者心房颤动的消融：治疗策略、连续房性心动过速的特征和长期结果。
J Am Heart Assoc. 2021 Feb 2;10(3):e017451. doi: 10.1161/JAHA.120.017451. Epub 2021 Jan 17.
2
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020年美国心脏协会/美国心脏病学会肥厚型心肌病患者诊断和治疗指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2020 Dec 22;142(25):e558-e631. doi: 10.1161/CIR.0000000000000937. Epub 2020 Nov 20.
3
Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.肥胖与肥厚型心肌病不良长期结局的相关性。
JAMA Cardiol. 2020 Jan 1;5(1):65-72. doi: 10.1001/jamacardio.2019.4268.
4
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.2017年心房颤动导管消融与外科消融专家共识声明：执行摘要（由心律学会/欧洲心律协会/欧洲心血管病预防与康复协会/亚太心律学会/拉丁美洲心脏电生理与心脏起搏学会发布）
Heart Rhythm. 2017 Oct;14(10):e445-e494. doi: 10.1016/j.hrthm.2017.07.009. Epub 2017 Sep 15.
5
Safety, Side Effects and Relative Efficacy of Medications for Rhythm Control of Atrial Fibrillation in Hypertrophic Cardiomyopathy.肥厚型心肌病心房颤动节律控制药物的安全性、副作用和相对疗效。
Am J Cardiol. 2019 Jun 1;123(11):1859-1862. doi: 10.1016/j.amjcard.2019.02.051. Epub 2019 Mar 13.
6
Clinical Course and Management of Hypertrophic Cardiomyopathy.肥厚型心肌病的临床病程与管理
N Engl J Med. 2018 Aug 16;379(7):655-668. doi: 10.1056/NEJMra1710575.
7
Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.肥厚型心肌病中心房颤动的临床特征和后果。
Circulation. 2017 Dec 19;136(25):2420-2436. doi: 10.1161/CIRCULATIONAHA.117.029267. Epub 2017 Sep 15.
8
Occurrence and Natural History of Clinically Silent Episodes of Atrial Fibrillation in Hypertrophic Cardiomyopathy.肥厚型心肌病患者临床无症状性房颤发作的发生率及自然病史
Am J Cardiol. 2017 Jun 1;119(11):1862-1865. doi: 10.1016/j.amjcard.2017.02.040. Epub 2017 Mar 16.
9
Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis.肥厚型心肌病患者房颤的导管消融治疗：一项系统评价和荟萃分析
Heart. 2016 Oct 1;102(19):1533-43. doi: 10.1136/heartjnl-2016-309406. Epub 2016 May 27.
10
Outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis.肥厚型心肌病患者心房颤动导管消融的结局：系统评价和荟萃分析。
Europace. 2016 Apr;18(4):508-20. doi: 10.1093/europace/euv339. Epub 2015 Nov 26.
Zotero 插件